138 related articles for article (PubMed ID: 12796387)
1. Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas.
Takahiro T; Shinichi K; Toshimitsu S
Clin Cancer Res; 2003 Jun; 9(6):2204-12. PubMed ID: 12796387
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma.
Horiguchi A; Asano T; Asano T; Ito K; Sumitomo M; Hayakawa M
J Urol; 2008 Sep; 180(3):1137-40. PubMed ID: 18639282
[TBL] [Abstract][Full Text] [Related]
3. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients.
Alo' PL; Visca P; Marci A; Mangoni A; Botti C; Di Tondo U
Cancer; 1996 Feb; 77(3):474-82. PubMed ID: 8630954
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
[TBL] [Abstract][Full Text] [Related]
5. Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study.
Silva SD; Agostini M; Nishimoto IN; Coletta RD; Alves FA; Lopes MA; Kowalski LP; Graner E
Oral Oncol; 2004 Aug; 40(7):688-96. PubMed ID: 15172638
[TBL] [Abstract][Full Text] [Related]
6. Expression of the lipogenic enzyme fatty acid synthase (FAS) as a predictor of poor outcome in nephroblastoma: an interinstitutional study.
Camassei FD; Jenkner A; Ravà L; Bosman C; Francalanci P; Donfrancesco A; Alò PL; Boldrini R
Med Pediatr Oncol; 2003 May; 40(5):302-8. PubMed ID: 12652618
[TBL] [Abstract][Full Text] [Related]
7. ErbB2 and fatty acid synthase (FAS) expression in 102 squamous cell carcinomas of the tongue: correlation with clinical outcomes.
Silva SD; Perez DE; Alves FA; Nishimoto IN; Pinto CA; Kowalski LP; Graner E
Oral Oncol; 2008 May; 44(5):484-90. PubMed ID: 17825601
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of CD100 expression in soft tissue sarcoma.
Ch'ng E; Tomita Y; Zhang B; He J; Hoshida Y; Qiu Y; Morii E; Nakamichi I; Hamada K; Ueda T; Aozasa K
Cancer; 2007 Jul; 110(1):164-72. PubMed ID: 17520683
[TBL] [Abstract][Full Text] [Related]
9. Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings.
Silva SD; Perez DE; Nishimoto IN; Alves FA; Pinto CA; Kowalski LP; Graner E
Oral Dis; 2008 May; 14(4):376-82. PubMed ID: 18410580
[TBL] [Abstract][Full Text] [Related]
10. Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas: a clinicopathologic study of 281 cases.
Sato O; Wada T; Kawai A; Yamaguchi U; Makimoto A; Kokai Y; Yamashita T; Chuman H; Beppu Y; Tani Y; Hasegawa T
Cancer; 2005 May; 103(9):1881-90. PubMed ID: 15772959
[TBL] [Abstract][Full Text] [Related]
11. The retinoblastoma family member pRb2/p130 is an independent predictor of survival in human soft tissue sarcomas.
Masciullo V; Berardengo E; Boglione A; Sgambato A; Bernardi A; Forni M; Linari A; Cito L; Scambia G; Comandone A; Giordano A
Clin Cancer Res; 2008 Aug; 14(15):4775-9. PubMed ID: 18676747
[TBL] [Abstract][Full Text] [Related]
12. Extent, relationship and prognostic significance of apoptosis and cell proliferation in synovial sarcoma.
Sun B; Sun Y; Wang J; Zhao X; Wang X; Hao X
Eur J Cancer Prev; 2006 Jun; 15(3):258-65. PubMed ID: 16679870
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas.
Weng WH; Ahlén J; Aström K; Lui WO; Larsson C
Clin Cancer Res; 2005 Sep; 11(17):6198-204. PubMed ID: 16144921
[TBL] [Abstract][Full Text] [Related]
14. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ
J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase expression in high grade soft tissue sarcomas.
Alford SH; Vrana MS; Waite L; Heim-Hall J; Sylvia VL; Williams RP
Oncol Rep; 2007 Dec; 18(6):1529-36. PubMed ID: 17982640
[TBL] [Abstract][Full Text] [Related]
16. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
17. Expression of decorin, a small leucine-rich proteoglycan, as a prognostic factor in soft tissue tumors.
Matsumine A; Shintani K; Kusuzaki K; Matsubara T; Satonaka H; Wakabayashi T; Iino T; Uchida A
J Surg Oncol; 2007 Oct; 96(5):411-8. PubMed ID: 17579351
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of O6-methylguanine-DNA methyltransferase in soft tissue sarcomas: association with K-ras mutations.
Kim JI; Suh JT; Choi KU; Kang HJ; Shin DH; Lee IS; Moon TY; Kim WT
Hum Pathol; 2009 Jul; 40(7):934-41. PubMed ID: 19356788
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of retroperitoneal soft tissue sarcomas: analysis of 132 cases.
Chen CQ; Yin L; Peng CH; Cai Y; Li YF; Zhao R; Zhou HJ; Li HW
Chin Med J (Engl); 2007 Jun; 120(12):1047-50. PubMed ID: 17637220
[TBL] [Abstract][Full Text] [Related]
20. [Pulmonary metastasectomy for osteosarcomas and soft tissue sarcomas].
Kimura H; Suzuki M; Ando S; Iida T; Iwata T; Tatesaki S; Isii T; Yonemoto T
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1319-23. PubMed ID: 15446550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
